Quantitative measures of blood flow and metabolism are essential for improved assessment of brain health and response to ischemic injury. In this report, we demonstrate a multimodal technique for measuring the cerebral metabolic rate of oxygen (CMRO 2 ) in the rodent brain on an absolute scale (M O 2 / min). We use laser speckle imaging (LSI) at 809 nm and spatial frequency domain imaging (SFDI) at 655 nm, 730 nm, and 850 nm to obtain spatiotemporal maps of cerebral blood flow (CBF), tissue absorption ( a ), and tissue scattering ( s '). Knowledge of these three values enables calculation of a characteristic blood flow speed, which in turn is input to a mathematical model with a "zero-flow" boundary condition to calculate absolute CMRO 2 . We apply this method to a rat model of cardiac arrest (CA) and cardiopulmonary resuscitation. With this model, the zero-flow condition occurs during entry into CA. The CMRO 2 values calculated with our method are in good agreement with those measured with magnetic resonance (MR) and positron emission tomography (PET) by other groups. Our technique provides a quantitative metric of cerebral metabolism that can potentially be used for comparison between animals and longitudinal monitoring of a single animal over multiple days, to assess differences in baseline metabolism and track recovery of metabolism in survival studies following ischemia and reperfusion.
Introduction
Assessing brain metabolism on a quantitative scale is critical for improved diagnosis, monitoring, and treatment of ischemic damage caused by conditions such as cardiac arrest (CA) and focal stroke. In particular, it is critical to measure the absolute cerebral metabolic rate of oxygen (CMRO 2 ), Such knowledge would obviate the need for baseline measurements and facilitate longitudinal measurements to track longer-term cerebral recovery following ischemia and reperfusion. Also, it is essential to measure absolute CMRO 2 to enable quantitative comparisons between the values of different subjects at baseline and at subsequent time points in preclinical or clinical studies. These needs are currently unmet, as no existing technology directly and noninvasively measures absolute CMRO 2 with high spatial and temporal resolution using endogenous contrast.
Conventional clinical monitoring techniques (e.g., arterial blood pressure, jugular bulb oximetry, pulse oximetry, laser Doppler flowmetry) are typically unable to separate alterations in cerebral metabolism from changes in blood flow. Measurement of CMRO 2 requires medical imaging techniques such as Positron Emission Tomography (PET) or functional Magnetic Resonance Imaging (fMRI). PET [1] [2] [3] [4] [5] can measure absolute CMRO 2 , but it is expensive, nonportable, and uses exogenous contrast agents containing radioactive tracers. fMRI measures CMRO 2 changes via the blood oxygen level dependent (BOLD) signal, but it struggles to provide absolute CMRO 2 without extensive calibration because it uses the BOLD signal as a surrogate for cerebral blood flow and hemoglobin content as opposed to directly measuring these quantities. Additionally, both PET and BOLD fMRI typically have limited temporal resolution and cannot be performed repeatedly on a patient over a short period.
Diffuse optical imaging (DOI) techniques are an inroad to addressing this problem, as they are noncontact and use non-harmful visible and near-infrared light to probe tissue absorption and scattering for endogenous contrast. Recently, we demonstrated that the combination of Spatial Frequency Domain Imaging (SFDI) and Laser Speckle Imaging (LSI)) can quantify tissue metabolic changes with high spatial and temporal resolution [6] . We also recently applied high-speed LSI [7] and SFDI [8] to measure perfusion, oxygenation, and tissue scattering in the brain in a cardiac arrest (CA) model of global cerebral ischemia. The capability of our rapid multimodal SFDI+LSI system to image blood flow and hemoglobin concentration simultaneously enables high-speed measurement of CMRO 2 [9] .
Previous optical methods to calculate CMRO 2 have typically used point source techniques [10] and intrinsic signals that do not correct for changes in tissue scattering [9, 11] .
However, by combining LSI and multispectral SFDI, we can account for the effects of timevarying tissue scattering at multiple wavelengths [12] and the contribution of venous regions versus parenchyma when calculating CMRO 2 . Furthermore, most optical techniques measure only the relative CMRO 2 , as they are unable to solve for the necessary quantities to calculate the absolute CMRO 2 . Therefore, these methods typically require measurement of a baseline before each imaging session, so that changes in CMRO 2 during the experiment can be assessed relative to that baseline. This approach makes it very difficult to perform quantitative longitudinal studies of metabolic changes over periods of days or weeks where multiple separate imaging sessions are required. By contrast, the combination of our multimodal instrumentation and CA model enables continuous measurement of absolute CMRO 2 during the dynamic cerebral ischemia and reperfusion phenomena caused by CA and resuscitation.
Here, we report a technology that uses multimodal optical imaging (LSI + SFDI), along with a mathematical model of CMRO 2 that incorporates a "zero-flow" boundary condition during the onset of ischemia in our CA model, to obtain the parameters necessary for absolute CMRO 2 measurement. By merging quantitative measurement of absolute CMRO 2 with highspeed resolution (up to ~14 Hz) of rapid changes in CMRO 2 during highly dynamic events (e.g., CA and reperfusion), our approach represents a significant potential step forward in quantitative metabolic imaging of the brain.
Methods

Animal Preparation
The Institutional Animal Care and Use Committee (IACUC) at the University of California, Irvine (protocol number 2013-3098-01) approved all of the procedures described in this report.
Ten male Wistar rats (weight ~300-400 g) were imaged for this study, and the animal preparation procedures are described in our previous publications [7, 8, 13, 14] . Before the experiment, all rats were endotracheally intubated under isoflurane anesthesia. Each rat had epidural screw electrodes implanted for electrocorticography (ECoG). Each rat was given a hemicraniectomy (4 mm right-to-left x 6 mm anterior-to-posterior), which enabled imaging of a portion of the right sensory and visual cortex. Cannulation of the femoral artery was performed to allow the delivery of drugs, the sampling of blood, and the monitoring of blood pressure. Fig. 1 shows the multimodal setup employed in the experiments. At the onset of each experiment, the level of isoflurane was decreased from 2% to 0.5-1%. Concurrently, the mixture of inhaled gases was altered from 50% O 2 + 50% N 2 to 100% O 2 . Two minutes later, to reduce confounding effects of isoflurane on cerebral perfusion and metabolism, the anesthesia was turned off entirely after an additional two minutes, at which time the rat was exposed to room air (21% O 2 ). During this same time period, 1 mL of 2 mg/kg Vecuronium (a neuromuscular blocker) and 1 mL of heparinized saline were administered intravenously, which enabled respiration to be controlled entirely by the ventilator. This stage of the experiment lasted for 3 min, after which the ventilator was turned off to induce asphyxia and cause progressive hypoxic hypercarbic hypotension. CA was defined as the period over which the pulse pressure decreased below 10 mmHg and systolic pressure below 30 mmHg. The conditions of these experiments induced pulseless electrical activity, which is common in CA patients in a hospital setting.
Cardiac Arrest (CA) and Cardiopulmonary Resuscitation (CPR)
Forty-five seconds before onset of CPR, the ventilator was turned back on (respiratory rate = 85 breaths/min, PIP = 17.5-18.5 cmH 2 O, PEEP = 3 cmH 2 O at 2.5 LPM), and 100% oxygen was given. Immediately before the onset of CPR, 0.01 mg/kg epinephrine, 1 mmol/kg sodium bicarbonate, and 2 mL of heparinized saline were administered intravenously. Then, CPR was performed via external cardiac massage. CPR was terminated upon return of spontaneous circulation (ROSC), as identified from arterial blood pressure measurements.
Subsequently, the animal was monitored continuously with arterial blood pressure, LSI, SFDI, and ECoG for an additional ~2 hr, after which the animal was euthanized with pentobarbital.
Recovery of ECoG signal following ROSC was quantified by (1) time to initial resumption (burst) of ECoG activity, and (2) ECoG Information Quantity (IQ) 90 min post-ROSC (as in [15] ).
Laser Speckle Imaging (LSI)
For LSI, an 809 nm laser with long coherence length (Ondax, Monrovia, CA) served as the light source. To make the illumination close to uniform, we placed a ground-glass diffuser (ThorLabs, Inc., Newton, NJ) between the laser and the tissue. A CCD camera (Point Grey Research Inc., Richmond, BC, Canada) detected the backscattered light with a 10 ms exposure time, enabling image acquisition at a frame rate of 60 Hz. Using a 5x5 sliding spatial window filter, the equation K = /<I> was employed to calculate the local speckle contrast K at each pixel, where <I> was the mean intensity over the window and  the standard deviation over the window [16] .
Then, the speckle flow index (SFI) was determined from the speckle contrast K and the exposure time T via a simplified speckle imaging equation SFI = 1/(2TK 2 ) [16] . Time-resolved SFI curves were generated by taking the mean of the SFI over a selected region of interest (ROI) at each time point.
Spatial Frequency Domain Imaging (SFDI)
For SFDI, light-emitting diodes (LEDs) of three different wavelengths (655 nm, 730 nm, 850 nm) were used as light sources. The light from the LEDs was directed to a spatial light modulator that projected square-wave patterns onto the brain [8] . Backscattered light was captured using a scientific complementary metal-oxide semiconductor (sCMOS) camera (Hamamatsu Photonics).
An Arduino board was used to synchronize the camera and LEDs so that images of each spatial pattern and wavelength were obtained sequentially. For each wavelength, four patterns were projected onto the tissue in sequence. The first pattern was non-modulated, and the three subsequent patterns were modulated at spatial frequency ~0.3/mm with three distinct spatial phases to enable demodulation [17] . Thus, there were a total of (3 wavelengths x 4 frames) = 12 frames in each sequence. At the spatial frequency of ~0.3/mm, the detected square wave pattern could be approximated as a sinusoid, allowing demodulation in the manner described by our group previously [18] . A full sequence of frames was needed to reconstruct tissue hemodynamics and CMRO 2 , resulting in an effective imaging rate of ~14 Hz.
After demodulating the spatially-modulated data, the diffuse reflectance at each time point and wavelength was calculated from the raw data via calibration against a tissue-simulating phantom with known optical properties [17] . The diffuse reflectance was then fit with a Monte Carlo model to extract the tissue absorption coefficient  a and reduced scattering coefficient  s ' [8] . Next, to improve the clarity of the  a maps, the average  s ' was determined for a selected ROI and a new μ a was determined using diffuse reflectance with the non-modulated pattern and this average  s '. To calculate the concentrations of oxygenated and deoxygenated hemoglobin (ctHbO 2 and ctHb, respectively) within the tissue, this new  a () spectrum was fit with the model spectrum  a () = 2.303(ctHbO 2 HbO 2 + ctHbHb). The total tissue hemoglobin concentration (ctHb tot ) was calculated by summing ctHb and ctHbO 2 . The tissue oxygen saturation was determined using the equation StO 2 = ctHbO 2 /(ctHbO 2 + ctHb).
Correction of speckle flow index for tissue absorption and scattering
To correct the measured SFI for tissue absorption and static scattering, the measured speckle contrast K was converted to a characteristic flow speed (v c ) by using the following equation [19] :
In this equation,  is a constant (typically set to 1) related to polarization and coherence properties of the LSI instrumentation. From the Siegert relationship, the intensity autocorrelation function G 2 () can be related to G 1 (), which, in turn, is described by the correlation diffusion equation:
In Eq. (2), q is the source term and  eff = (3 a,dyn  tr ) 1/2 , where  tr = ( a +  s ') is the tissue transport coefficient and  a,dyn = ( a +  s 'k o 2 <r 2 ()>/3) is the dynamic tissue absorption coefficient [19] . In the equation for  a,dyn , <r 2 ()> is the mean square displacement of the moving scatterers (i.e., the red blood cells) and k o is the photon wavenumber. Solving Eq. (2), G 1 () can be written as:
In Eq. (3), P o is the incident optical power, and A is a function of the tissue refractive index [17] .
All other terms in Eq. 
Absolute cerebral metabolic rate of oxygen (CMRO 2 ) calculation
To calculate absolute CMRO 2 , we start from the equation [21] : oxygen that was extracted from that arteriole and used by the brain for metabolic processes related to the synthesis of ATP. This quantity is equivalent to the concentration of deoxygenated hemoglobin that arrived in a venule following oxygen extraction by the brain. Therefore, within our measurement paradigm [6] , Eq. (4) is re-written as:
In Eq. (5) The factor (Hb bl /<ctHb tot > p ) accounts for partial-volume effects caused by the diffuse nature of light propagation in the brain. Eq. (4) requires an intra-vascular oxygen concentration, but we measure a bulk tissue deoxyhemoglobin concentration. Hence, a blood-volume fraction term is required to convert between these two quantities. The numerator, Hb bl , is the concentration of hemoglobin in the blood sampled from the femoral artery of the animal during the arterial blood gas measurement (ABG). The denominator, <ctHb tot > p , is the mean total tissue hemoglobin concentration in the parenchyma during the period that the ABG was acquired. The factor (Hb bl /<ctHb tot > p ) enables the required conversion of our optical ctHb measurements from the scale of a tissue hemoglobin concentration to the scale of a vascular hemoglobin concentration, removing the partial volume effect and allowing us to measure CMRO 2 on an absolute scale.
The parameter  is a typically unknown constant; thus, the quantity reported in optical brain imaging studies is usually the relative CMRO 2 (rCMRO 2 ), since the  factor can be eliminated when calculating rCMRO 2 . However, in this report, we were able to measure absolute CMRO 2 by using a "zero-flow" boundary condition [22] , which is provided by the onset of cerebral ischemia in our animal model:
This procedure was performed for each of the 10 rats in this study, using the values of SFI and ctHb v during the period immediately before asphyxia (t->t asph -) and the mean rate of change dctHb v /dt immediately after the onset of asphyxia (t->t asph + ). The values of  and absolute CMRO 2 then were calculated over the entire craniectomy region at each measurement time point.
To our knowledge, this report represents the first high-speed diffuse optical imaging measurement of absolute CMRO 2 in the brain with high temporal resolution during a preclinical study. Maps of absolute CMRO 2 throughout a representative CA/CPR experiment are shown in Fig. 3 . At baseline, the animal is under anesthesia (2% isoflurane). After 2 min of anesthesia washout, the CMRO 2 increases by a factor of ~2 as the animal is waking up. Following the onset of ischemia, the CMRO 2 drops precipitously as the animal enters CA. After resuscitation, the CMRO 2 rapidly increases until reaching a maximum at ~8 min post-CPR (during hyperemia).
Results
Subsequently, the CMRO 2 drops back toward baseline as ECoG bursting begins (~12 min post-CPR). Representative time courses of absolute CMRO 2 values for regions of interest in the parenchyma of two representative rats are shown in Fig. 5(a) . Interestingly, the rat with the higher baseline CMRO 2 values required less time to resume ECoG activity (bursting) following CPR and had a higher ECoG IQ 90 min post-ROSC. For the 10 subjects included in this study, we observed that, regardless of CA duration, higher absolute CMRO 2 values at baseline correlated significantly with cerebral electrical activity (ECoG IQ) 90 min post-CPR (Spearman; r = 0.75; p = 0.026) ( Fig. 5(b) ). These data collectively suggest that the absolute CMRO 2 measurement at baseline may be predictive of cerebral electrical recovery following CA and CPR. 
Discussion
In this report, we provide, to the best of our knowledge, the first demonstration of dynamic imaging of absolute cerebral metabolic rate of oxygen (CMRO 2 ) in the living brain using a combination of laser speckle and spatial frequency domain techniques. We use the tissue absorption and reduced scattering coefficients measured with SFDI to account for the effects of optical properties on our interpretation of the LSI information. We then use the "zero-flow" condition inherent in our CA experimental paradigm to solve for the coefficient  in the CMRO 2 equation by using a continuity condition at the boundary between normal flow and zero-flow states. Using this technique, we perform quantitative spatial mapping of absolute CMRO 2 continuously throughout the different stages of the CA + CPR experiment. The CMRO 2 obtained from our optical system agreed well with established brain imaging techniques (PET, MRI/MRS). Furthermore, we show a significant correlation between absolute CMRO 2 values at baseline, and longer-term cerebral electrical recovery (ECoG IQ 90 min post-CPR), regardless of CA duration.
This paradigm for measuring CMRO 2 removes the long-standing requirement that a baseline measurement is acquired, as the CMRO 2 is now on an absolute quantitative scale (in units of M O 2 /min) and can thus be directly compared between animals or across multiple separate imaging sessions on different days for a single animal. This enables longitudinal monitoring of cerebral recovery for days or weeks following ischemia and reperfusion without need for a baseline and perturbation (e.g., a gas challenge) on each measurement day. The methods described here are potentially widely applicable to quantitative measurement of metabolic recovery and flow-metabolic coupling and uncoupling in preclinical models of ischemic conditions such as CA and stroke.
Optical Imaging Segments Venous Regions to Better Quantify Cerebral Oxygen Extraction
The imaging capability of our device allows the segmentation of a region of interest atop a prominent vein, which enables more accurate measurements of the quantity of deoxygenated venous blood and, hence, the quantity of oxygen consumed by the brain. With the use of a larger region of interest, the local CMRO 2 would be systematically underestimated due to inclusion of the parenchyma in the region; oxygen extraction in the parenchyma is lower than in individual vessels. CMRO 2 models of diffuse light transport implicitly assume that the concentration of deoxygenated hemoglobin is that within the veins specifically, and not the bulk tissue [26] .
However, most diffuse-optics CMRO 2 measurements are practically unable to satisfy this condition, as they typically use fiber-based spectroscopic techniques that sample the bulk tissue and thus cannot distinguish between venous and mixed arterial-venous parenchymal regions. In this report, the use of diffuse optical imaging allows us to use deoxyhemoglobin concentrations measured in a venous ROI to overcome this limitation and thus obtain more accurate quantitative values of CMRO 2 .
Correction of CMRO 2 Data for Partial-Volume Effects
Furthermore, most diffuse-optics measurements of absolute CMRO 2 are hampered by the partialvolume effect, as the CMRO 2 equation requires a measurement of the concentration of deoxyhemoglobin within the vein itself, not within the tissue as a whole. Therefore, typical diffuse-optics measurements of hemoglobin concentrations in bulk tissue are roughly two orders of magnitude lower than the concentration of hemoglobin in the vein itself. Here, we overcome this limitation by introducing a partial-volume correction to the CMRO 2 equation. This correction allows us to convert the bulk tissue hemoglobin concentration into an intravascular hemoglobin concentration. Without this correction factor, the CMRO 2 values would also be underestimated by two orders of magnitude. To accurately incorporate this scaling term, it is necessary to know the concentration of total hemoglobin (Hb bl ) within the blood of each animal.
In this report, these values were acquired via arterial blood gas (ABG) measurement before CA.
There was a non-negligible amount of variation (mean = 11.95 g/dL; standard deviation = 1.55 g/dL) among the Hb bl values of the 10 subjects in this study. Therefore, failing to account for the variation in Hb bl between the different rats could introduce an additional error of ~12-25% in the measured CMRO 2 due specifically to within-group variability in Hb bl values.
Contributions of Directed Flow versus Diffuse Flow
It is important to note that when we solved for the characteristic flow speed in this report, we assumed that all of the corrected flow speed could be attributed to a "directed-flow" term (Eq. 2).
Previous studies have used a Brownian diffusion term as the free parameter when fitting for flow speed [27] or constrained the fit in a model system such that one could choose to fit for either diffuse or directed flow but not both simultaneously [20] . Recently, Postnov et al. [28] used high-speed LSI to map the autocorrelation function pixel-by-pixel in the rodent brain, identifying the dominant type of particle motion at each pixel. In that study, the directed flow term was dominant in large vessels, while the diffuse-motion term was dominant in the parenchyma.
Here, we could not rigorously solve for the autocorrelation function because the sampling frequency of our LSI data acquisition was too low to perform a method similar to that of Postnov et al. [28] . Instead, we used a two-step approach of (1) using SFDI data to account for the effects of optical properties on interpreting the LSI data, and (2) fitting the resulting corrected data to a model of directed flow to extract the characteristic flow speed. This method provided characteristic flow speeds that were similar to previously-reported values [29] .
To examine the effect of including both diffuse and directed motion as free parameters in a single model, we used an alternate algorithm ( Fig. 7) in which the absorption-and staticscatter-corrected CBF data were fit with a linear combination of both diffuse flow and directed flow, to determine the relative contribution of each type of motion at each pixel. This model extracted a diffusion coefficient that was roughly homogeneous over the entire imaged region (1.4x10 -5 ± 0.7x10 -5 mm 2 /s in large vessel ROI at baseline; 1.5x10 -5 ± 0.8x10 -5 mm 2 /s in parenchyma ROI at baseline). Also, this model extracted directed flow speeds that were higher in the large vessels (0.78 ± 0.05 mm/s in large vessel ROI at baseline) than in the parenchyma (0.45 ± 0.07 mm/s in parenchyma ROI at baseline). These results support the finding of Postnov et al.
[28] that the directed-flow term dominates in the large vessels and the diffuse-flow term contributes more notably in the parenchyma.
Both the directed-flow term and the diffuse-flow term were considerably reduced during ischemia (CA). The extracted diffusion coefficient and directed flow speed obtained with this two-term model were both similar to previously-reported values [27, 29, 30] . When the directedflow term alone was used in the model, the extracted characteristic flow speeds were 0.83 ± 0.04 mm/s in the large vessel ROI and 0.52 ± 0.03 mm/s in the parenchyma ROI for the rat shown in Fig. 7 . Therefore, using only directed flow in the model is expected to introduce only a small discrepancy (~10%) in the extracted flow speed, relative to using the two-term approach.
Limitations of Zero-Flow Condition
Our current approach for measuring absolute CMRO 2 requires temporary induction of a "zeroflow" condition in the brain. In this report, this condition was met by using a CA model in rats.
However, there is a clear need to investigate alternative approaches for interrogating absolute CMRO 2 without creating harmful perturbations. Future work can incorporate techniques such as temporarily clamping the middle cerebral artery [31] or administering sub-lethal doses of potassium chloride [32] to temporarily induce a zero-flow condition that can be quickly reversed without long-term harm to the animal. It is important to note that once this procedure is performed once on a given animal, subsequent measurements on that same animal should not require additional instances of that procedure. Although the comparison of absolute CMRO 2 calculated with our approach with PET and MRI is encouraging, further comparison work is required with measurements collected from the same animals under identical anesthesia conditions. Future work is warranted.
Conclusion
In this report, we have described, to the best of our knowledge, the first mapping of the absolute cerebral metabolic rate of oxygen (CMRO 2 ) in the rat brain using diffuse optical imaging. The CMRO 2 allows for quantitative assessment of the cerebral metabolism without the need for baseline measurements, enabling longitudinal comparison between animals and between multiple days of measurement on an absolute scale. The CMRO 2 measurements provided by our multimodal system were in good agreement with those previously measured in the brain of anesthetized rats using PET and MRI. This method shows significant potential for assessing and monitoring cerebral metabolism and predicting cerebral response to ischemic injury. is performed to provide direct access to the brain for optical imaging. For SFDI, light-emitting diodes (LEDs) of 655 nm, 730 nm, and 850 nm are sequentially sent into a spatial light modulator that acts as a projector to send spatially-modulated patterns of light onto the brain [8] .
A scientific CMOS camera detects the backscattered light. For LSI, an 809 nm laser illuminates the brain with coherent light, and the remitted speckle pattern is captured at 60 fps with a CCD camera. 90 min post-CPR. Blue dots are rats with mild (5 min) ischemia duration, and red dots are rats with prolonged (7 min) ischemia duration. These results suggest that the initial value of CMRO 2 (pre-injury) may be predictive of cerebral electrical recovery following ischemia and reperfusion. Diffuse and directed flow maps obtained from the brain of a representative rat at baseline, global ischemia (CA), and hyperemic reperfusion post-CPR using a two-term model (one diffusion term, one directed-flow term) to fit to the optical property-corrected LSI data. As expected, during the periods when the brain is perfused, the directed-flow term is high in the large vessels and low in the parenchyma, while the diffusion coefficient is homogeneous in distribution. During CA, the directed-flow term vanishes nearly completely, and the diffusion coefficient is reduced to values more similar to those in static media. 
